Geoffrey Ku, MD, Discusses New Non-Immunotherapy Targets and Therapies in GI Cancer

At the virtual Great Debates & Updates in Gastrointestinal (GI) Malignancies, Geoffrey Ku, MD, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, provided an overview of new non-immunotherapy targets and drugs in the GI cancer space.

https://www.oncnet.com/conference-insider/geoffrey-ku-md-discusses-new-non-immunotherapy-targets-and-therapies-gi-cancer

Leave a comment



Leave a Reply

Your email address will not be published. Required fields are marked *